Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2007 1
2008 2
2009 7
2010 3
2011 4
2012 4
2013 15
2014 13
2015 14
2016 15
2017 8
2018 15
2019 6
2020 11
2021 26
2022 25
2023 21
2024 23
2025 31
2026 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

220 results

Results by year

Filters applied: . Clear all
Page 1
Tumour Burden Score as a Predictor of Extrahepatic Progression After Transarterial Chemoembolization for Hepatocellular Carcinoma: An Observational Multicenter Study.
Pinto E, Pelizzaro F, Simeon V, Bucci L, Gambato M, Vitale A, Sangiovanni A, Cabibbo G, Ghittoni G, Svegliati-Baroni G, Boninsegna S, Trevisani F, Foschi FG, Stefanini B, Saitta C, Azzaroli F, Marra F, Vidili G, Mega A, Zaccherini G, Brunetto MR, Grasselli S, Ponziani FR, Morisco F, Sacco R, Magalotti D, Nardone G, Di Marco M, Martini A, Sacerdoti D, Farinati F, Giannini EG, Russo FP; ITA.LI.CA study group. Pinto E, et al. Among authors: cabibbo g. Aliment Pharmacol Ther. 2026 May;63(9):1282-1296. doi: 10.1111/apt.70534. Epub 2026 Jan 14. Aliment Pharmacol Ther. 2026. PMID: 41531314
Reproducibility of segmentation and radiomic features in contrast-enhanced CT images of early, intermediate and advanced HCC patients: a multicenter study.
Fanni SC, Maria GD, Aghakhanyan G, Braccischi L, Celsa C, Cannella R, Cabibbo G, Enea M, Francischello R, Masi G, Matranga D, Marseglia M, Mosconi C, Pecorelli A, Salani F, Stefanini B, Vivaldi C, Cammà C, Piscaglia F, Lencioni R, Cioni D. Fanni SC, et al. Among authors: cabibbo g. Eur J Radiol. 2026 Apr 26;201:112889. doi: 10.1016/j.ejrad.2026.112889. Online ahead of print. Eur J Radiol. 2026. PMID: 42068759
Determinants of long-term survival from atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.
Lee PC, Cortellini A, Stefanini B, Yoo C, Chon HJ, Cheon J, Kudo M, Nishida N, Scheiner B, Pinter M, Lombardi P, Fulgenzi CAM, D'Alessio A, Brunetti L, Torkpour A, Valenzi E, Crowley F, Marron TU, Hsu WF, Celsa C, Cabibbo G, Cammà C, Galle PR, Vivaldi C, Masi G, Sharma R, Lin RP, Lin CY, Wietharn B, Saeed A, Tovoli F, Piscaglia F, Dalbeni A, Auriemma A, Sacerdoti D, Parisi A, Manfredi GF, Dondo A, Rimassa L, Pirisi M, Schönlein M, von Felden J, Singal AG, Parkih ND, Andanamala H, Ulahannan S, Roehlen N, Thimme R, Huang YH, Pinato DJ. Lee PC, et al. Among authors: cabibbo g. Eur J Cancer. 2026 Apr 16;240:116749. doi: 10.1016/j.ejca.2026.116749. Online ahead of print. Eur J Cancer. 2026. PMID: 42030777 Free article.
PHENO-RAG: An artificial intelligence tool for guideline-informed management decisions in hepatocellular carcinoma.
Celsa C, Giuffrè M, Di Maria G, Gruttadauria S, Palazzo U, Miraglia R, Maruzzelli L, Pagano D, Cannella R, Midiri F, Ciccia R, Salvato M, Grova A, Rao S, Giusino G, Quartararo A, Cusimano G, Sparacino A, Gaudioso V, Genovese V, Montenegro R, La Mantia C, Mercurio F, Kresevic S, Ajcevic M, Cabibbo G, Cirrincione G, Cammà C. Celsa C, et al. Among authors: cabibbo g. JHEP Rep. 2026 Apr;8(4):101715. doi: 10.1016/j.jhepr.2025.101715. Epub 2025 Dec 19. JHEP Rep. 2026. PMID: 41830877 Free PMC article.
The Effect of Metformin on Atezolizumab/Bevacizumab Treatment in Patients with Hepatocellular Carcinoma and Diabetes.
Dalbeni A, Vicardi M, Natola LA, Auriemma A, Stefanini B, Vivaldi C, Federico P, Polloni A, Soldà C, Lani L, Garajová I, Tamberi S, De Lorenzo S, Piscaglia F, Di Maria V, Masi G, Lonardi S, Brandi G, Daniele B, Trevisani F, Svegliati-Baroni G, Schiada L, Marra F, Campani C, Celsa C, Cabibbo G, Bruccoleri M, Iavarone M, Stella L, Ponziani FR, Pressiani T, Rimassa L, Tovoli F, Sacerdoti D. Dalbeni A, et al. Among authors: cabibbo g. Oncol Res. 2026 Mar 23;34(4):16. doi: 10.32604/or.2026.073063. eCollection 2026. Oncol Res. 2026. PMID: 41930153 Free PMC article.
Reproducible safety and efficacy of durvalumab with or without tremelimumab for hepatocellular carcinoma in clinical practice: Results of the DT-real study.
Celsa C, Pressiani T, Nishida N, Chamseddine SM, Arvind A, Li M, Fortuny M, Khaled NB, Iavarone M, Toyoda H, Rapposelli IG, Casadei-Gardini A, Vivaldi C, Ulahannan S, Andanamala H, Scheiner B, Pinter M, Orlandi E, Fulgenzi CAM, Manfredi GF, Lombardi P, D'Alessio A, Stefanini B, Villani R, Ponziani FR, Stella L, Carminati O, Ricci AD, Gonzalez M, Sparacino A, Di Maria G, Vaccaro M, Cabibbo G, Cammà C, Reig M, Kelley RK, Singal AG, Kaseb AO, Kudo M, Rimassa L, Pinato DJ. Celsa C, et al. Among authors: cabibbo g. JHEP Rep. 2025 Nov 20;8(3):101685. doi: 10.1016/j.jhepr.2025.101685. eCollection 2026 Mar. JHEP Rep. 2025. PMID: 41675370 Free PMC article.
Long-term outcomes of atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A real-world study.
Tovoli F, Iavarone M, Cabibbo G, Marra F, Vivaldi C, Dalbeni A, Ponziani FR, Palloni A, Bergamo F, Rimassa L, Lani L, Federico P, Svegliati-Baroni G, Ielasi L, Mazzarelli C, De Lorenzo S, Sacco R, Bruccoleri M, Celsa C, Mastro A, Masi G, Auriemma A, Stella L, Toniutto P, Villani R, Lonardi S, Pressiani T, Piscaglia F; ARTE study group. Tovoli F, et al. Among authors: cabibbo g. Hepatology. 2026 Feb 25. doi: 10.1097/HEP.0000000000001725. Online ahead of print. Hepatology. 2026. PMID: 41746328
The use of advanced machine learning to predict outcomes after atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: a retrospective cohort study.
Vithayathil M, Manfredi GF, D'Alessio A, Fulgenzi CAM, Celsa C, Lombardi P, Torkpour A, Stefanini B, Galle PR, Nishida N, Scheiner B, Crowley F, Wu L, Ang C, Marron TU, Hsu WF, Lin CY, Lin RP, Ulahannan SV, Andanamala H, Soror N, Kaseb A, Lapelusa M, Mohamed YI, Schönlein M, von Felden J, Schulze K, Wege H, Wietharn B, Vivaldi C, Salani F, Masi G, Pressiani T, Dalbeni A, Natola L, Marseglia M, Piscaglia F, Huang YH, Lee PC, Pirisi M, Parisi A, Rohlen N, Thimme R, Silletta M, Di Giacomo E, Vincenzi B, Galbato L, Vogel A, Cabibbo G, Camma C, Jae Chon H, Pinter M, Cortellini A, Kudo M, Zanuso V, Rimassa L, Pinato DJ, Aboagye EO, Sharma R. Vithayathil M, et al. Among authors: cabibbo g. Lancet Digit Health. 2026 Feb;8(2):100952. doi: 10.1016/j.landig.2025.100952. Epub 2026 Feb 12. Lancet Digit Health. 2026. PMID: 41688234 Free article.
220 results